Table 1.
| |||||
---|---|---|---|---|---|
compd | R | X | tubulin assembly IC50 ± SDa (μM) | MCF-7 IC50 ± SDb,c (nM) | colchicine binding inhibitionc,d (% ± SD) |
6 | 4-Br | S | 2.4 ± 0.1 | 400 ± 70 | 33 ± 2 |
7 | 4-Br | C=O | >20 (partial activity)e | 430 ± 100 | ndf |
8 | 4-Cl | S | 1.6 ± 0.07 | 290 ± 50 | 48 ± 5 |
9 | 4-Cl | C=O | 3.6 ± 0.2 | 260 ± 50 | 38 ± 3 |
10 | 4-Cl | CH2 | 17 ± 0.2 | >5000 | nd |
11 | 4-F | S | 1.7 ± 0.07 | 80 ± 30 | 80 ± 0.4 |
12 | 4-F | C=O | 1.6 ± 0.08 | 65 ± 7 | 63 ± 1 |
13 | 4-MeO | S | >20 (partial activity)e | 1400 ± 300 | nd |
14 | 4-MeO | C=O | >20 (no activity)g | >5000 | nd |
15 | 5-Br | S | 1.3 ± 0.1 | 320 ± 100 | 39 ± 3 |
16 | 5-Br | C=O | >40 | 530 ± 100 | nd |
17 | 5-Br | CH2 | 4.0 ± 0.5 | 700 ± 300 | 31 ± 2 |
18 | 5-Cl | S | 1.5 ± 0.2 | 280 ± 70 | 49 ± 5 |
19 | 5-Cl | C=O | >20 | 330 ± 100 | nd |
20 | 5-Cl | CH2 | 4.4 ± 0.8 | 310 ± 10 | 38 ± 3 |
21 | 5-F | S | 1.5 ± 0.1 | 300 ± 0 | 61 ± 4 |
22 | 5-F | C=O | 13 ± 0.4 | 240 ± 90 | nd |
23 | 5-OMe | S | 2.1 ± 0.01 | 200 ± 80 | 58 ± 0.5 |
24 | 5-OMe | C=O | 8.3 ± 1 | 170 ± 60 | nd |
25 | 5-OMe | CH2 | 3.5 ± 0.4 | 100 ± 0 | 41 ± 0.9 |
26 | 6-Br | S | 1.9 ± 0.2 | 9.0 ± 2 | 87 ± 0.6 |
27 | 6-Br | C=O | 1.3 ± 0.2 | 30 ± 2 | 86 ± 0.4 |
28 | 6-Cl | S | 1.2 ± 0.2 | 20 ± 10 | 88 ± 3 |
29 | 6-Cl | C=O | 1.4 ± 0.06 | 35 ± 7 | 71 ± 5 |
30 | 6-Cl | CH2 | 1.6 ± 0.01 | 55 ± 20 | 72 ± 6 |
31 | 6-F | S | 2.4 ± 0.2 | 80 ± 20 | 74 ± 2 |
32 | 6-F | C=O | 10 ± 0.4 | 600 ± 0 | nd |
33 | 6-MeO | S | 1.1 ± 0.1 | 1.3 ± 0.6 | 96 ± 1 |
34 | 6-MeO | C=O | 1.2 ± 0.06 | 30 ± 10 | 95 ± 0.4 |
35 | 7-Br | S | 1.6 ± 0.2 | 25 ± 5 | 82 ± 1 |
36 | 7-Br | C=O | 1.7 ± 0.1 | 4.0 ± 0.5 | 72 ± 0.3 |
37 | 7-Cl | S | 1.3 ± 0.2 | 50 ± 10 | 82 ± 0.3 |
38 | 7-Cl | C=O | 1.8 ± 0.05 | 9.0 ± 1 | 69 ± 0.5 |
39 | 7-Cl | CH2 | 2.4 ± 0.2 | 200 ± 0 | 50 ± 4 |
40 | 7-F | S | 1.0 ± 0.1 | 20 ± 9 | 92 ± 0.3 |
41 | 7-F | C=O | 1.7 ± 0.1 | 30 ± 0 | 67 ± 3 |
42 | 7-OMe | S | 1.2 ± 0.01 | 19 ± 10 | 87 ± 2 |
43 | 7-OMe | C=O | 1.8 ± 0.1 | 200 ± 0 | 62 ± 3 |
44 | 6,7-Cl2 | S | 1.2 ± 0.1 | 7.0 ± 3 | 92 ± 2 |
45 | 6,7-Cl2 | C=O | 1.5 ± 0.03 | 15 ± 5 | 93 ± 0.7 |
1 | 3.2 ± 0.4 | 5.0 ± 1 | nd | ||
2 | 1.0 ± 0.1 | 13 ± 3 | 98 ± 0.6 | ||
3h | 3.3 ± 0.1 | 52 ± 7 | nd | ||
4i | 2.0 ± 0.2 | 13 ± 3 | 93 ± 0.8 | ||
5i | 2.5 ± 0.3 | 42 ± 10 | 76 ± 0.2 |
Inhibition of tubulin polymerization. Tubulin was at 10 μM in the assembly assay.
Inhibition of growth of MCF-7 human breast carcinoma cells.
Compounds that inhibited tubulin assembly with IC50 ≤ 5 μM were tested in the cellular and colchicine binding assays.
Inhibition of [3H]colchicine binding. Tubulin was at 1 μM. Both [3H]colchicine and inhibitor were at 5 μM.
Partial inhibition at 20 μM.
No data.
Little or no activity at 20 μM.
Reference 15.
Reference 16.